Guardant Health Prices $500 Million in Notes to Refinance 2027 Debt
Guardant Health announced in a November 12, 2026 pricing release that it priced $500 million of 0% convertible senior notes due 2032 in a private offering, with plans to repurchase its convertible notes due 2027 and fund capped-call transactions. The refinancing plan assumes the initial purchasers fully exercise an option to buy another $50 million of notes and Guardant enters into the additional capped-call transactions. Guardant expects to use approximately $501.7 million of the resulting net…